Pay in 4 interest-free payments of $6.67 Learn more
Ships within 48 hours · Estimated delivery Nov 1 - Nov 6
Because IGF-1 influences cellular growth and glucose regulation pathways, dosing should only occur under physician supervision
Tirzepatide also replaces our GIP hormone which is an additional way in aiding weight loss and increasing insulin release
The most commonly reported psychological symptoms include: Mood changes and irritability Some patients describe feeling more emotionally labile, experiencing mood swings, or becoming more easily frustrated during treatment Anxiety symptoms Reports of increased worry, restlessness, or generalised anxiety have been documented, though these may also relate to lifestyle changes or pre-existing tendencies Depressive symptoms A subset of patients report low mood, loss of interest in activities, or feelings of sadness Suicidal ideation Rare reports of suicidal thoughts have been investigated by regulatory authorities, though no causal relationship has been established In the pivotal STEP clinical trial programme for Wegovy, psychiatric adverse events were generally low and similar between the semaglutide and placebo groups
Book Your Consultation Now Both medications can be effective tools in a structured, medically supervised weight loss plan
ZA and DJM are principal investigators and made contributions to the design of the study, acquisition (DJM) and interpretation of the data, and revision of the manuscript
US$ 22.59
US$ 28.42
US$ 26.47
US$ 28.56
US$ 29.74
US$ 20.24
